Medibank Pvt Ltd
MPL: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$5.50 | Hvrwn | Snhywlcr |
Medibank Making the Most of a Pandemic With Good Policyholder Growth and Margin Improvement.
Medibank reported a 27% increase in first-half profit to AUD 226 million. On balance the result is not far off what we expected, but we lower our fiscal 2021 profit forecast by 3% on slower premium growth. Our long-term forecasts and AUD 2.90 fair value estimate are maintained.